Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - cell+therapy
65
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
A Biosensor Engineering Strategy for Improved Cell-based Therapy
NU 2016-174 Inventors Joshua N. Leonard* Kelly A. Schwarz Rachel M. Dudek Short Description A sophisticated multiplexed biosensor system that can activate a downstream promoter to effect diverse custom biological functions. #therapeutics #cellsignaling #healthcare #diagnostictool Background The market for cell-based therapeutics has gained wide...
Published: 5/12/2026
|
Updated: 5/12/2026
|
Inventor(s):
Keywords(s):
Biotechnology
,
Cell therapy
,
Research tool
,
Sensors
,
Synthetic biology
Category(s):
Life Sciences > Biomarkers & Biomedical Research Tools
An All-In-One “Swiss Army Knife” Tool To Edit Genes And Regulate Their Expression Without Off-Target Effects And Toxicity
A flexible toolkit for human gene editing, activation, and repression that can be applied in orthogonally and in various disease models. Problem: There is increasing demand for technologies that can simultaneously edit the genome and regulate the transcriptome without relying on toxic double-stranded breaks. Currently, treating complex diseases such...
Published: 5/5/2026
|
Updated: 5/5/2026
|
Inventor(s):
Xue Sherry Gao
,
Tyler Daniel
,
Hongzhi Zeng
,
Qichen Yuan
Keywords(s):
Bioengineering
,
Cell Therapy
,
Gene Editing
,
Genetic Disorders
,
Neurodegenerative Diseases
,
Obesity Metabolic Disease and Diabetes
,
Oncology
,
Orphan Disease
,
Pulmonary
Category(s):
Technology Classifications > Research Tools & Reagents
,
Technology Classifications > Therapeutics
MPL Protein Targeting for Cancer Therapy and Transplant Preparation
Application Non-genotoxic hematopoietic stem cell transplantation conditioning regimen. Key Benefits Selective depletion of hematopoietic stem cells creates adequate niche space to allow donor engraftment without significant off target effect. Non-genotoxic conditioning regimen. CAR-T cells can have an anti-MPL positive leukemia effect before...
Published: 4/27/2026
|
Updated: 4/27/2026
|
Inventor(s):
Shanmuganathan (Shan) Chandrakasan
,
H. (Harold) Trent Spencer
,
Christopher Doering
,
Lauren Fleischer
,
Gianna Branella
,
Jaquelyn Zoine
,
Harrison Brown
Keywords(s):
Antibodies
,
Cell Therapy
,
Oncology Treatments
Category(s):
TechPub Algolia > Therapeutics
Orthogonal Synthetic Receptors for IL-23
SHORT DESCRIPTION Synthetic IL-23 receptors for cell engineering to enable real-time sensing and drive precise autoimmune and cancer immunotherapy interventions. INVENTORS Joshua Leonard* McCormick School of Engineering, Department of Chemical and Biological Engineering Aaron Morris William Corcoran ...
Published: 5/8/2026
|
Updated: 4/14/2026
|
Inventor(s):
Keywords(s):
Autoimmune disease
,
Cell engineering
,
Cell therapy
,
Diagnostics
,
IBD - Inflammatory bowel disease
,
Immunology
,
Immunotherapy
,
Inflammation
,
Targeted therapy
,
Therapeutics
Category(s):
Life Sciences > Therapeutics
,
Life Sciences > Biomarkers & Biomedical Research Tools
Responsive Probiotic Therapy for Local Detection and Treatment of IBD Flares
SHORT DESCRIPTION An engineered probiotic that senses intestinal inflammation via calprotectin and locally releases therapeutic antibodies in the gastrointestinal tract only during inflammatory flares. INVENTORS Arthur Prindle* McCormick School of Engineering, Department of Chemical and Biological Engineering Jonathan...
Published: 5/11/2026
|
Updated: 4/14/2026
|
Inventor(s):
Keywords(s):
Autoimmune disease
,
Biologic
,
Cell therapy
,
Diagnostics
,
Gastrointestinal and Hepatic disease
,
IBD - Inflammatory bowel disease
,
Immunology
,
Immunotherapy
,
Inflammation
,
Synthetic biology
,
Therapeutics
Category(s):
Life Sciences > Therapeutics
Next Gen Immune-Optimized Gene Delivery
Application An advanced gene therapy approach that improves therapeutic efficiency by protecting transgene expressing cells from host immune responses, through modulation of a key immune checkpoint pathway. Key Benefits Enhanced efficiency across viral and non-viral gene delivery systems, including AAV, lentivirus, LNPs, and electroporation. Enables...
Published: 3/11/2026
|
Updated: 2/23/2026
|
Inventor(s):
Matthew (Matt) Gardner
,
Michael Kuipa
,
Abubakarr Koroma
,
Isai Leguizamo
Keywords(s):
Biologics
,
Cell Therapy
,
Gene Therapy and Editing
,
Immunology and Inflammation Treatments
,
Oncology Treatments
,
Platform
,
Regenerative Medicine
Category(s):
TechPub Algolia > Therapeutics
Anticancer IgG Against Multiple Epitopes on Live Tumors Upon Disruption of ‘Self’ Signaling by CD47
A method to combine two or three monoclonal antibodies (mABs) into one treatment to successfully bind to multiple cancer cell surface epitopes and promote targeted degradation by phagocytosis. Problem: Phagocytosis of ‘self’ cells is generally inhibited by a key macrophage checkpoint interaction between SIRPα on the macrophage and...
Published: 12/15/2025
|
Updated: 12/15/2025
|
Inventor(s):
Dennis Discher
,
Jason Andrechak
,
Lawrence Dooling
Keywords(s):
Antibody
,
Bioengineering
,
Cell Therapy
,
Drug Target
,
Immunology
,
Immunoncology
,
Immunotherapy
,
Oncology
,
Platform Technology
Category(s):
Technology Classifications > Therapeutics
Engineered B-
cell Therapy
for Cancer Treatment
NU 2022-218 INVENTORS Catalina Lee Chang* Maciej Lesniak* SHORT DESCRIPTION Engineered B cells with reduced expression of key immune checkpoint proteins designed to boost cancer immunotherapy efficacy. BACKGROUND Immunotherapy has transformed cancer treatment; however, its application to brain tumors remains limited by the immunosuppressive...
Published: 4/8/2026
|
Updated: 12/3/2025
|
Inventor(s):
Keywords(s):
Cancer/Oncology
,
Cell therapy
,
Immunotherapy
,
Targeted therapy
,
Therapeutics
Category(s):
Life Sciences > Therapeutics
Protein Polymers for Organelle Engineering
Application Protein polymers enabling engineering of human membraneless organelles. Key Benefits Versatile applications across immunotherapy,
cell therapy
, and other therapeutic modalities. High biocompatibility with minimal reactivity with endogenous molecules. Deployable for organelle-level functionalization of human cells. Market Summary Proteins...
Published: 3/10/2026
|
Updated: 11/7/2025
|
Inventor(s):
Felipe Quiroz
,
Ian Sicher
,
Spencer Hayes
,
Maria Giraldo-Castaño
,
Mariell Pascual
,
Alexa Avecilla
Keywords(s):
Biomaterials
,
Cell Therapy
,
Immunotherapy
,
Protein and Peptide Therapeutics
,
Regenerative Medicine
,
Research Tools
Category(s):
TechPub Algolia > Therapeutics
T Cells Targeting Misformed Proteins to Treat Neurodegenerative and Muscular Diseases
Antigen-specific immunotherapy with engineered cytotoxic T cells targeting misformed proteins to treat neurodegenerative and muscular diseases. Problem: Neurodegenerative and muscular diseases, such as amyotrophic lateral sclerosis (ALS), inclusion body myositis (IBM), and Alzheimer’s disease (AD), collectively affect over 5 million adults...
Published: 11/11/2025
|
Updated: 10/30/2025
|
Inventor(s):
Ning Jenny Jiang
,
Shahab Chizari
Keywords(s):
Bioengineering
,
Cell Therapy
,
Immunology
,
Immunotherapy
,
Inflammation
,
Neurodegenerative Diseases
Category(s):
Technology Classifications > Diagnostics
,
Technology Classifications > Research Tools & Reagents
,
Technology Classifications > Therapeutics
1
2
3
4
5
6
7